Abstract/Overview
Objective—We aimed to determine whether endothelial activation biomarkers increase after HIV-1 acquisition, and whether biomarker levels measured in chronic infection would predict disease progression and death in HIV-1 seroconverters.
M., G (2024). Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression. Afribary. Retrieved from https://tracking.afribary.com/works/endothelial-activation-biomarkers-increase-after-hiv-1-acquisition-plasma-vcam-1-predicts-disease-progression
M., Graham "Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression" Afribary. Afribary, 16 Jul. 2024, https://tracking.afribary.com/works/endothelial-activation-biomarkers-increase-after-hiv-1-acquisition-plasma-vcam-1-predicts-disease-progression. Accessed 12 Nov. 2024.
M., Graham . "Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression". Afribary, Afribary, 16 Jul. 2024. Web. 12 Nov. 2024. < https://tracking.afribary.com/works/endothelial-activation-biomarkers-increase-after-hiv-1-acquisition-plasma-vcam-1-predicts-disease-progression >.
M., Graham . "Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression" Afribary (2024). Accessed November 12, 2024. https://tracking.afribary.com/works/endothelial-activation-biomarkers-increase-after-hiv-1-acquisition-plasma-vcam-1-predicts-disease-progression